LIV Emles at Home ETF

Samaritan Pharmaceuticals Inc. (AMEX:LIV) -- David W. Munno, Merrill Lynch VP of biotechnology, stated, "Large-cap biotech firms need some blockbuster products for meaningful growth which is more than likely to come from small- to mid-sized biotechs." -- Vinny Jindal, of Think Equity Partners LLC, stated, "Small-cap biotech is going to have a banner year." Samaritan Pharmaceuticals Inc., a developer of innovative drugs, announced today that biotech analysts at Bio 2006 in Chicago, the industry's largest conference, predicted encouraging trends for small-caps like Samaritan. Dr. Greeson, CEO of Samaritan, stated, "We found a much stronger interest in our blockbuster technology than ever before at Bio 2006, which we think might confirm the analyst predictions that large-caps need product. We also found a warm reception to explore in-licensing opportunities to market and distribute niche products in Greece and Eastern Europe. We are extremely pleased with the interest we have garnered." Samaritan Pharmaceuticals: "We LIV....to Save Lives." Samaritan is a small-cap biotech, driven to discover, develop, and commercialize, innovative therapeutics for AIDS, Alzheimer's, cancer and heart disease. Look at www.samaritanpharma.com. Please register on our Web site so we can notify you of upcoming conference calls, news and events. Disclaimer The company disclaims any information that is created by an outside party and endorses only information that is communicated by its press releases, filings and Web site. This news release contains forward-looking statements that reflect management's current beliefs about the potential for its drug candidates, science and technology. However, as with any biopharmaceutical under development, there are significant risks and uncertainties in the process of development and regulatory review. There are no guarantees that products will prove to be commercially successful. For additional information about the factors that affect the company's business, please read the company's latest Form 10-K filed April 15, 2005. The company undertakes no duty to update forward-looking statements.